What health economic studies were identified for high risk, mid-length intervention, MDT clinic category?
One health economic study was identified for the high risk, mid-length intervention, MDT clinic category. This study was conducted by Sahlen [Sweden] and was a partially applicable cost-utility analysis with potentially serious limitations. The population studied was adults with chronic heart failure with NYHA class III-IV symptoms and a marker of severity, and the intervention studied was MDT consisting of a heart failure nurse, palliative care nurse, cardiologist, palliative care physician, physiotherapist and occupational therapist. The study found a 6 month follow-up saving of QALYs (more effective and less costly). Uncertainty was not reported for cost effectiveness, however the conclusions were robust to sensitivity analyses.